£2.86m
Not reported the period beforeActive15999109Private limited companyOxford
SCRIPTA THERAPEUTICS LIMITED
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Scripta Therapeutics Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Scripta Therapeutics Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
SCRIPTA THERAPEUTICS LIMITED is an active private limited company (company number 15999109) incorporated on 4 October 2024, registered in Oxford. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2025, showing net assets of £2.86m and cash of £2.42m, with 5 employees on average.
Peer position · net assets
By net assets it sits in the top quarter of 152 comparable companies in Oxford (median £10k, upper quartile £474k).
02
Ownership and control
No active person with significant control is registered.
- Dr Peter Richard John Hamley
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 4 October 20242 yrs ago
- Next accounts due
- 30 September 2027in 340 days
- Confirmation statement due
- 18 October 2027in 358 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Small
- Size band
- MicroCompanies Act thresholds
05
Financials
£2.42m
Not reported the period beforeNot reported
5
vs Oct 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | £2.86m | £2.42m | — | £658k | — | −£1.79m | 5 |
| 3 October 2024 | — | — | — | — | — | — | 0 |
Current ratio4.44Current assets ÷ creditors within one year
Cash per employee£485kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £2,864,971 at 31 December 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 4.44
- Cash at bank of £50,000 or moreCash £2,424,318
- Incorporated two to five years agoIncorporated 4 October 2024
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 358 days
- Next accounts duein 340 days
- Accounts period endNet assets £2.86m · small accounts
- Incorporated
- Accounts period end
08
Similar companies in Oxford
09
Reminders for SCRIPTA THERAPEUTICS LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.